Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 14, 2024 08:22 ET
Leading Law Firm Bleichmar Fonti & Auld LLP announces an investigation of WideOpenWest, Inc.’s (NYSE: WOW) potential merger with DigitalBridge Investments, LLC; Contact the Firm for More Details
If you invested in WideOpenWest you are encouraged to obtain additional information by contacting Ross Shikowitz at [email protected], https://www.bfalaw.com/cases/wideopenwest-inc-investigation, or calling us at 212-789-3619. There is no cost to...
May 14, 2024 08:15 ET
Gratus Capital Partners with iCapital® to Launch Hedge Fund Investing Opportunities to Wealth Management Clients
Gratus Capital (“Gratus”), an Atlanta-based investment advisory firm, announced today a partnership with iCapital[1], the global fintech platform driving access to alternative investments for the wealth management industry. The collaboration will...
May 14, 2024 08:15 ET
Newton Golf Shafts Helps Propel Doug Barron to His First Major Championship on the PGA TOUR Champions
Newton Golf Shafts, a business division of Sacks Parente Golf, Inc. (Nasdaq: SPGC) (“SPG” or the “Company”), announces that Doug Barron, a member of Newton Shafts’ roster, clinched his first major championship on the PGA TOUR Champions at the...
May 14, 2024 08:15 ET
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024
STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its installed...
May 14, 2024 08:10 ET
American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Conference Call
American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday,...
May 14, 2024 08:07 ET
DRFortress Expands Cloud Connectivity Capabilities for Hawaii Businesses with Megaport Cloud Connect
DRFortress, the largest carrier-neutral data center and cloud marketplace operating in Hawaii, announces that it has launched a new public cloud on-ramp solution with Megaport, a global pioneer in Network as a Service (NaaS) solutions, to offer...
May 14, 2024 08:06 ET
Sysco Celebrates Arrival of Heavy-Duty Electric Vehicles in Its Headquarters City of Houston, TX, Growth of Electric Fleet Globally
Sysco is hosting a news conference to celebrate the arrival of new heavy duty electric vehicles to the company’s hometown Houston distribution facility, the first for Sysco in Texas. The company will also announce its progress in deploying EVs...
May 14, 2024 08:05 ET
Bitcoin Depot Reports First Quarter 2024 Financial Results
Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, today reported financial results for the first quarter ended March 31, 2024. Bitcoin Depot will host a conference call and webcast...
May 14, 2024 08:05 ET
OpsMx Receives Coveted Industry Recognition
OpsMx, the secure software delivery company, today announced it has garnered recognition from three key industry award programs. OpsMx received a Bronze Stevie Award for OpsMx Delivery Shield in the DevOps Solution category. The company was also...
May 14, 2024 08:05 ET
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today...
May 14, 2024 08:00 ET
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous...
May 14, 2024 08:00 ET
Franklin Electric Appoints Joe Ruzynski as CEO; Gregg Sengstack Remains Executive Chairperson
Franklin Electric Co., Inc. (NASDAQ: FELE), a global leader in water and energy systems, announced today that its Board of Directors has appointed Joe Ruzynski as Chief Executive Officer and a member of the Board, effective July 1, 2024. Gregg...
May 14, 2024 08:00 ET
Ocugen Provides Business Update with First Quarter 2024 Financial Results
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today reported first quarter 2024 financial results along with a...
May 14, 2024 08:00 ET
Middlefield Banc Corp. Announces 2024 Second-Quarter Cash Dividend Payment
Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per common share. The second-quarter dividend is payable on June 14, 2024, to shareholders of record on May 31, 2024....
May 14, 2024 08:00 ET
89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis
89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the initiation of...
May 14, 2024 08:00 ET
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each...
May 14, 2024 08:00 ET
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced that it has entered into a non-dilutive, senior secured credit facility with Sixth Street, a leading global investment firm, of up to $475 million, with approximately $375 million funded...
May 14, 2024 08:00 ET
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that an independent...
May 14, 2024 08:00 ET
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the...
May 14, 2024 08:00 ET
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid diethylamide (“LSD”), announced it...